Guinea-Bissau blocks hepatitis B newborn trial after authorization failure
Frederik Schaltz-Buchholzer announced on LinkedIn on October 21 that a controversial clinical trial on hepatitis B vaccination at birth would not go ahead in Guinea-Bissau. He said the researchers had not obtained the administrative authorization required for…
